Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

28.79
+0.36011.27%
Post-market: 28.800.0142+0.05%16:10 EDT
Volume:16.29K
Turnover:469.57K
Market Cap:234.46M
PE:- -
High:28.85
Open:28.73
Low:28.73
Close:28.43
52wk High:31.30
52wk Low:25.44
Shares:8.15M
Float Shares:8.15M
Volume Ratio:0.67
T/O Rate:0.20%
Dividend:0.49
Dividend Rate:1.72%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Halozyme Director Dannielle Appelhans Files Initial Beneficial Ownership Statement

Reuters
·
Aug 22

Halozyme CEO Helen Torley Sells USD 4.13 Million in Common Shares

Reuters
·
Aug 20

Soccer-Sheffield United's Ex-Owners Winds up Company Which Bought Club

Reuters
·
Aug 19

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2

Reuters
·
Aug 19

Halozyme Appoints COUR Pharma CEO Dannielle Appelhans to Board

Reuters
·
Aug 19

Halozyme Appoints Dannielle Appelhans to Its Board of Directors

THOMSON REUTERS
·
Aug 19

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.
·
Aug 18

Sagtec announces commercial launch of HALO AI Food-Serving Robot

TIPRANKS
·
Aug 18

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

Reuters
·
Aug 14

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Reuters
·
Aug 12

Halozyme Director Bernadette Connaughton Disposes of 1.626 Shares Worth $167.152,8

Reuters
·
Aug 12

Federal Reserve's diluted forward guidance fails to curb rate hike expectations, markets await July CPI for next rate path clues

Deep News
·
Aug 11

What Halozyme Therapeutics (HALO) Guidance Raise Means For Valuation

Simply Wall St.
·
Aug 11

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

Reuters
·
Aug 11

Bullion Rebounds Rely on Rate Path Evaluation

Deep News
·
Aug 10

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.
·
Aug 10

RBC Capital Remains a Buy on GH Research (GHRS)

TIPRANKS
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Halozyme price target raised to $105 from $93 at Morgan Stanley

TIPRANKS
·
Aug 07

Halozyme Therapeutics, Inc. : Leerink Partners Raises to Outperform from Market Perform; Raises Target Price to $110 from $83

THOMSON REUTERS
·
Aug 07